IGM Biosciences (STU:1K0) Beginning Cash Position : €104.06 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is IGM Biosciences Beginning Cash Position?

IGM Biosciences's Beginning Cash Position for the quarter that ended in Mar. 2024 was €104.06 Mil.

IGM Biosciences's quarterly Beginning Cash Position increased from Sep. 2023 (€141.81 Mil) to Dec. 2023 (€160.85 Mil) but then declined from Dec. 2023 (€160.85 Mil) to Mar. 2024 (€104.06 Mil).

IGM Biosciences's annual Beginning Cash Position declined from Dec. 2021 (€213.36 Mil) to Dec. 2022 (€126.53 Mil) and declined from Dec. 2022 (€126.53 Mil) to Dec. 2023 (€111.80 Mil).

IGM Biosciences Beginning Cash Position Historical Data

The historical data trend for IGM Biosciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IGM Biosciences Beginning Cash Position Chart

IGM Biosciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

1.79

29.50

213.36

126.53

111.80

IGM Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															113.87	129.98	141.81	160.85	104.06

IGM Biosciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

IGM Biosciences Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of IGM Biosciences's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

IGM Biosciences (STU:1K0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IGM Biosciences Inc (STU:1K0) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

IGMS:USA

Address

325 East Middlefield Road, Mountain View, CA, USA, 94043

Website

https://www.igmbio.com

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.

IGM Biosciences (STU:1K0) Headlines

No Headlines